News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Huang Jane
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| Huang Jane (President, CMO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Exercised 9,375 restricted stock units
@ $0 |
|
| 07/06/2023 |
4
| Huang Jane (President, CMO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Paid exercise price by delivering 3,242 shares
@ $4.65, valued at
$15.1k
Exercised 9,375 restricted stock units
@ $0 |
|
| 06/08/2023 |
4
| Huang Jane (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 02/09/2023 |
4
| Huang Jane (President, CMO) has filed a Form 4 on Prelude Therapeutics Inc|
Txns:
| Granted 150,000 options to buy
@ $7.2, valued at
$1.1M
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2022 |
3
| Huang Jane (President, CMO) has filed a Form 3 on Prelude Therapeutics Inc |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 1,500 shares
@ $119.96, valued at
$179.9k
Sold 200 shares
@ $376.155, valued at
$75.2k
Sold 300 shares
@ $377.14, valued at
$113.1k
Sold 100 shares
@ $377.92, valued at
$37.8k
Sold 100 shares
@ $379.8839, valued at
$38k
Sold 200 shares
@ $381.41, valued at
$76.3k
Sold 100 shares
@ $382.42, valued at
$38.2k
Sold 100 shares
@ $384.16, valued at
$38.4k
Sold 100 shares
@ $385.28, valued at
$38.5k
Sold 300 shares
@ $387.94, valued at
$116.4k
Exercised 19,500 options to buy
@ $0 |
|
| 10/21/2021 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 1,500 shares
@ $119.96, valued at
$179.9k
Sold 200 shares
@ $362.045, valued at
$72.4k
Sold 100 shares
@ $370.14, valued at
$37k
Sold 100 shares
@ $371.65, valued at
$37.2k
Sold 400 shares
@ $373.75, valued at
$149.5k
Sold 400 shares
@ $375.08, valued at
$150k
Sold 200 shares
@ $376.36, valued at
$75.3k
Sold 100 shares
@ $377.71, valued at
$37.8k
Exercised 19,500 options to buy
@ $0 |
|
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 6,914 shares
@ $160.4, valued at
$1.1M
Exercised 8,831 shares
@ $119.96, valued at
$1.1M
Exercised 5,255 shares
@ $174.43, valued at
$916.6k
Sold 2,379 shares
@ $330.5264, valued at
$786.3k
Sold 6,523 shares
@ $331.7875, valued at
$2.2M
Sold 8,177 shares
@ $332.7121, valued at
$2.7M
Sold 2,823 shares
@ $333.6385, valued at
$941.9k
Sold 1,000 shares
@ $334.846, valued at
$334.8k
Sold 98 shares
@ $335.76, valued at
$32.9k
Exercised 89,882 options to buy
@ $0
Exercised 114,803 options to buy
@ $0 |
|
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 1,500 shares
@ $29.49, valued at
$44.2k
Sold 200 shares
@ $244.8952, valued at
$49k
Sold 300 shares
@ $246.0233, valued at
$73.8k
Sold 200 shares
@ $247.975, valued at
$49.6k
Sold 200 shares
@ $249.875, valued at
$50k
Sold 300 shares
@ $251.5833, valued at
$75.5k
Sold 300 shares
@ $252.8633, valued at
$75.9k
Exercised 19,500 options to buy
@ $0 |
|
| 12/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2020 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 1,500 shares
@ $29.49, valued at
$44.2k
Sold 1,261 shares
@ $299.8765, valued at
$378.1k
Sold 139 shares
@ $300.7032, valued at
$41.8k
Sold 100 shares
@ $301.51, valued at
$30.2k
Exercised 19,500 options to buy
@ $0 |
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2020 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Sold 1,000 shares
@ $232.2469, valued at
$232.2k
Sold 1,411 shares
@ $232.9354, valued at
$328.7k
Sold 500 shares
@ $234.17, valued at
$117.1k
Sold 217 shares
@ $235.2133, valued at
$51k
|
|
| 09/01/2020 |
4
| Huang Jane (CMO, Hematology) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Exercised 3,000 shares
@ $29.49, valued at
$88.5k
Sold 800 shares
@ $240.1516, valued at
$192.1k
Sold 200 shares
@ $240.86, valued at
$48.2k
Sold 1,000 shares
@ $242.413, valued at
$242.4k
Sold 700 shares
@ $243.4886, valued at
$170.4k
Sold 300 shares
@ $244.9267, valued at
$73.5k
Exercised 39,000 options to buy
@ $0 |
|
| 07/31/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|